Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
03/2003
03/19/2003EP1292186A1 Animal and cell models for type ii diabetes and their use
03/19/2003EP1178984B1 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
03/19/2003EP1177195B1 1-AMINO TRIAZOLO 4,3-a! QUINAZOLINE-5-ONES AND OR -5-THIONES INHIBITING PHOSPHODIESTERASE IV
03/19/2003EP1157019B1 4-alkenyl (and alkynyl) oxindoles as inhibitors of cyclin-dependent kinases, in particular cdk2
03/19/2003EP1102579B1 Medicinal aerosol formulations
03/19/2003EP1082344B1 Glycoproteins having lipid mobilising properties and therapeutic applications thereof
03/19/2003EP1080069B1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase
03/19/2003EP1060162B1 Urethanes derived from azacycloalkanes, thio and dithio analogues, production and use thereof as 2,3 epoxysqualene lanesterol cyclase inhibitors
03/19/2003EP1056768B1 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
03/19/2003EP1037637B1 Use of 5ht1a receptor antagonists for preventing and/or treating temporal lobe epilepsy
03/19/2003EP1011686A4 Modulation of human mast cell activation
03/19/2003EP0981359B1 Compositions for enhancing immunosuppressants' pharmacological activities
03/19/2003EP0973390A4 Retinoid related molecules for the inhibition of endothelin-1 overproduction in disease
03/19/2003EP0918504B1 Use of genistein as a preventive agent against ultraviolet radiation induced skin photodamage and cancer
03/19/2003EP0910409A4 Recombinant constructs encoding t cell receptors specific for human hla-restricted tumor antigens
03/19/2003EP0900203B1 Quinoline derivatives, processes for their preparation, and their use as medicaments
03/19/2003EP0876482B1 Il-13 receptor polypeptide
03/19/2003EP0839157B1 Colostrum derived growth factor
03/19/2003EP0831798B1 Use of selegiline to treat hearing loss in mammals
03/19/2003EP0745094B1 Superagonists and antagonists of human il-6, and method for their selection
03/19/2003EP0670904B1 Vector for the expression of therapy-relevant genes
03/19/2003EP0657520B1 Antioxidant
03/19/2003EP0463101B2 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations
03/19/2003CN1404488A NOGO receptor-mediated blockade of axonal growth
03/19/2003CN1404482A Pteridine compounds for the treatment of psoriasis
03/19/2003CN1404481A Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of PDE4 isozymes
03/19/2003CN1404480A Pyrimidine carboxamides useful as inhibitors of PDE4 isozymes
03/19/2003CN1404479A Novel 1,3-dihydro-2H-indol-2-one derivatives their preparing method and the pharmceutical composition containing the same
03/19/2003CN1404478A Pyridinylimidazoles
03/19/2003CN1404476A Glycosidase inhibitors and preparation thereof
03/19/2003CN1404474A Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
03/19/2003CN1404468A Novel use of phenylheteroalkylamine derivatives
03/19/2003CN1404467A Aminosulfonylbiphenyl derivatives
03/19/2003CN1404402A Radioactive therapeutic Liposomes
03/19/2003CN1404400A Use of IL-18 inhibitors
03/19/2003CN1404395A Antiadhesive carbohydrates
03/19/2003CN1404394A Pharmaceutical compositions containing steroidal structures and uses thereof
03/19/2003CN1404392A Antiviral azaindole derivatives
03/19/2003CN1404391A Treating allergic and inflammatory conditions
03/19/2003CN1404390A TNF-alpha inhibitors
03/19/2003CN1404387A Cosmetic preparations containing plant extracts
03/19/2003CN1404382A Squalane containing ultra fine particles of burning residue of carbon and method for producing the same
03/19/2003CN1403474A Short peptide and medicine with short peptide as active component
03/19/2003CN1403157A Method for treating female sexual dysfunction and evaluating compound for treating female sexual dysfunction
03/19/2003CN1403081A Application of tadins inhibiting formation of osteoclast
03/19/2003CN1403079A Application of chuanliansu as specific P-type calcium passage blocker
03/19/2003CN1403076A Multi-particle improved release composition
03/19/2003CN1103335C Processfor producing 2,5-disubstituted pyridines
03/18/2003WO2002024637A1 Substituted cinnamic acid guanidides, method for the production thereof, their use as a medicament, and to a medicament containing these compounds
03/18/2003US6535943 Information processing device enabling floating interrupt to be pending and a method executing an interrupt condition change instruction
03/18/2003US6534655 Indeno[1,2-C]pyrazole derivatives for inhibiting tyrosine kinase activity
03/18/2003US6534652 Intermediates for the preparation of substituted 1,2,3,4-tetrahydronaphthalene derivatives
03/18/2003US6534643 Isolated nucleic acid of given sequence; useful for homology-dependent pairing of three DNA strands; use in cloning and gene mapping
03/18/2003US6534635 Tissue inhibitors of metalloproteinase (TIMP); electron-accepting group causes it to lose its ability to bind to metalloproteinase; carbamylation; inhibition of metastasis of cancer or vascularization
03/18/2003US6534633 Polyspecific binding molecules and uses thereof
03/18/2003US6534630 Connective tissue growth factor-2
03/18/2003US6534539 Pharmaceutical composition and method for treatment of dyspepsia
03/18/2003US6534534 Administering indazole-3-methyleneoxyalkanoic acid derivative to treat atherosclerosis
03/18/2003US6534530 Administering (benzo)thiazole peptidomimetic as viricide; protease inhibitors
03/18/2003US6534519 Phenanthridine-N-oxides with PDE-IV inhibiting activity
03/18/2003US6534518 Polysubstituted 6-phenylphenanthridines with PDE-IV inhibiting activity
03/18/2003US6534517 A polycyclic or heteropolycyclic compound containing amide or carboxy groups useful in the treatment and/or prevention of conditions mediated by nuclear receptors, in particular the peroxisome proliferator-activated receptor(PPAR)
03/18/2003US6534511 The use of certain 6-arylpyrazolo(3,4-d)pyrimidin-4-ones, 2 arylquinazolin-4-ones, 2-arylpurin-6-ones and 2-arylpyrido(3,2- d)pyrimidin-4-ones, or a pharmaceutically acceptable salt thereof, forsexual disorders
03/18/2003US6534510 Anticoagulants
03/18/2003US6534509 Derivatives are useful as anti-inflammatory agents. This invention is also directed to pharmacetutical compostions for inflammation
03/18/2003US6534504 Increasing the quantity of meat or improving the quality of meat obtained from a livestock animal, comprising administering to the animal an effective amount of a compound represented by the following structural formula:
03/18/2003US6534499 For therapy of autoimmune disease
03/18/2003US6534498 Protease inhibitors
03/18/2003US6534497 Substitute 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
03/18/2003US6534495 Anticoagulants that prevent thrombin-related diseases.
03/18/2003US6534490 Unsaturated 14, 15-cyclopropanoandrostanes, method for the production thereof and pharmaceutical preparations containing said compounds
03/18/2003US6534488 32P or 33P-labelled bisphosphonates as radiotherapeutic radiopharmaceuticals. The 32P- or 33P-labelled bisphosphonates, which are chemically identical to the unlabelled agent, are expected to target the lesion site in
03/18/2003US6534486 With broad anti-inflammatory properties which inhibit leukocyte recruitment and activation and which are agonists of the adenosine 2a receptor are described.
03/18/2003US6534483 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods
03/18/2003US6534478 Cyclic azapeptides with angiogenic effect
03/18/2003US6534476 Smad6 and uses thereof
03/18/2003US6534300 Methods for producing highly phosphorylated lysosomal hydrolases
03/18/2003US6534299 Peptide for use in development of human diagnostics and therapeutics; for use in deection and treatment of cancer, inflammation, immune disorders and development defects
03/18/2003US6534093 Immediate release eplerenone compositions
03/18/2003US6534087 Process for preparing a pharmaceutical composition
03/18/2003US6534056 Therapeutic and diagnostic uses of protein tyrosine phosphatase TC-PTP
03/18/2003US6534048 Aqueous gel in unit dose form for topical delivery
03/18/2003US6533819 Injectable implants for tissue augmentation and restoration
03/18/2003CA2678495A1 Disinfectant composition including quaternary ammonium salt and alkanolamine
03/18/2003CA2422709A1 Substituted cinnamic acid guanidides, method for the production thereof,their use as a medicament, and to a medicament containing these compounds
03/18/2003CA2360311C Improved dialysis solutions and methods
03/18/2003CA2272705C Fused bicyclic pyrimidine derivatives
03/18/2003CA2244501C Arylsulfonylamino hydroxamic acid derivatives
03/18/2003CA2217351C Carbonyl-piperazinyl and piperidinyl compounds which inhibit farnesyl protein transferase
03/18/2003CA2176840C Combination of an antimicrobial compound with a glycerol monoalkylether
03/17/2003CA2403157A1 Dna encoding the baboon and cynomolgus macaque prostaglandin e2 receptor ep4 subtype
03/17/2003CA2403058A1 Dna encoding the chimpanzee prostaglandin e2 receptor ep4 subtype
03/13/2003WO2004043335A2 Methods of treating infection by drug resistant bacteria
03/13/2003WO2003021273A2 Diagnosis of carcinomas
03/13/2003WO2003021263A1 Use of g protein-coupled receptor protein
03/13/2003WO2003020949A2 Targeted nucleic acid constructs and uses related thereto
03/13/2003WO2003020947A2 Mid 9002, a human sulfatase family member and uses therefor
03/13/2003WO2003020932A1 Novel secretory proteins and dna thereof
03/13/2003WO2003020920A1 Culture system for rapid expansion of human embryonic stem cells
03/13/2003WO2003020892A2 Bv8 NUCLEIC ACIDS AND POLYPEPTIDES WITH MITOGENIC ACTIVITY
1 ... 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 ... 1564